• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.

    3/7/25 4:05:37 PM ET
    $BFLY
    Medical Electronics
    Health Care
    Get the next $BFLY alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 6)


    Butterfly Network, Inc.

    (Name of Issuer)


    Class A common stock, par value $0.0001 per share, Class B common stock, par value $0.0001 per share

    (Title of Class of Securities)


    124155102

    (CUSIP Number)


    Jonathan M. Rothberg, Ph.D.
    c/o Butterfly Network, Inc., 1600 District Avenue
    Burlington, MA, 01803
    (781) 557-4800

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    03/05/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    Rothberg Jonathan M.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    8,866,114.00
    8Shared Voting Power

    726,696.00
    9Sole Dispositive Power

    8,866,114.00
    10Shared Dispositive Power

    726,696.00
    11Aggregate amount beneficially owned by each reporting person

    9,592,810.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    4.4 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class A common stock. Rows 7, 9 and 11 consists of (i) 2,641,924 shares of Class A common stock of Butterfly Network, Inc. (f/k/a Longview Acquisition Corp.) (the "Issuer") held by Jonathan M. Rothberg, Ph.D., (ii) stock options to purchase 21,645 shares of Class A common stock of the Issuer which are exercisable within 60 days of March 7, 2025, held by Dr. Jonathan M. Rothberg, (iii) 6,202,545 shares of Class A common stock of the Issuer distributed from 2012 JMR Trust Common, LLC and held by entities owned by trusts created for the benefit of Dr. Jonathan Rothberg's children. Rows 8, 10 and 11 consists of 726,696 shares of Class A common stock of the Issuer held by Dr. Rothberg's spouse. Row 13 is calculated based on 216,496,214 shares of Class A common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    Rothberg Jonathan M.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    26,426,937.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    26,426,937.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    26,426,937.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    100 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Rows 7, 9 and 11 consists of 26,426,937 shares of Class B common stock of the Issuer held by 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC and 4C Holdings V, LLC. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings I, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    9,716,596.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    9,716,596.00
    11Aggregate amount beneficially owned by each reporting person

    9,716,596.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    36.8 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings II, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,621,701.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,621,701.00
    11Aggregate amount beneficially owned by each reporting person

    2,621,701.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.9 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings III, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,621,701.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,621,701.00
    11Aggregate amount beneficially owned by each reporting person

    2,621,701.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.9 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings IV, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,621,701.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,621,701.00
    11Aggregate amount beneficially owned by each reporting person

    2,621,701.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.9 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings V, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    8,845,238.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    8,845,238.00
    11Aggregate amount beneficially owned by each reporting person

    8,845,238.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    33.5 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A common stock, par value $0.0001 per share, Class B common stock, par value $0.0001 per share
    (b)Name of Issuer:

    Butterfly Network, Inc.
    (c)Address of Issuer's Principal Executive Offices:

    1600 District Avenue, Burlington, MASSACHUSETTS , 01803.
    Item 1 Comment:
    Explanatory Note This Amendment No. 6 to Schedule 13D ("Amendment No. 6") amends and supplements the Schedule 13D filed on February 22, 2021, as amended by Amendment No. 1 filed on March 26, 2021, Amendment No. 2 filed on March 28, 2022, Amendment No. 3 filed on September 16, 2022, Amendment No. 4 filed on September 13, 2023 and Amendment No. 5 filed on August 30, 2024 (as amended, the "Schedule 13D") relating to the Class A common stock, par value $0.0001 per share, and Class B common stock, par value $0.0001 per share, of Butterfly Network, Inc. (f/k/a Longview Acquisition Corp.), a Delaware corporation (the "Issuer"). Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 6. Capitalized terms used but not defined herein have the meanings ascribed to them in the Schedule 13D.
    Item 4.Purpose of Transaction
     
    Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: In connection with estate planning, entities owned by trusts created for the benefit of Dr. Jonathan Rothberg's children have entered into a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Plan"), a copy of which is attached hereto as Exhibit 5. Pursuant to the Plan, sales of up to 6,202,545 shares of Class A common stock may be effected during the plan sales period beginning following the cooling-off period contained in Rule 10b5-1(c) on July 7, 2025 and ending on July 3, 2026 in accordance with the terms and conditions of the Plan. The sale of shares of Class A common stock under the Plan is subject to minimum price parameters included in the Plan, and there is no assurance that any shares of Class A common stock will be sold under the Plan.
    Item 7.Material to be Filed as Exhibits.
     
    Item 7 of the Schedule 13D is hereby amended by adding the following exhibit: Exhibit No. 5 - Rule 10b5-1 Trading Plan

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Rothberg Jonathan M.
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D.
    Date:03/07/2025
     
    Rothberg Jonathan M.
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D.
    Date:03/07/2025
     
    4C Holdings I, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings II, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings III, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings IV, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings V, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
    Get the next $BFLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BFLY

    DatePrice TargetRatingAnalyst
    8/1/2025Outperform → Perform
    Oppenheimer
    7/1/2025$3.00Buy
    Craig Hallum
    3/17/2025Outperform
    William Blair
    9/10/2024$3.00Buy
    Lake Street
    3/29/2023$2.25Neutral
    UBS
    11/29/2022$4.50Outperform
    Oppenheimer
    10/4/2022$9.50Buy
    B. Riley Securities
    12/17/2021$7.00Neutral
    UBS
    More analyst ratings

    $BFLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on February 26 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

    2/3/26 8:01:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market

    ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global medical imaging market hit a massive $45.5 billion in 2026[1], marking a total structural shift toward AI-native precision as advanced cancer therapies demand more intense heart monitoring than ever before[2]. Hospitals are ditching expensive, bulky hardware for agile, cloud-based platforms that deliver MRI-quality results without the MRI-sized price tag. This pivot has catapulted the cardiac AI diagnostic sector to $2.22 billion this year[3], driven by a desperate need for continuous imaging to catch heart dysfunction caused by cancer treatments[4]. Thi

    1/27/26 10:14:00 AM ET
    $BFLY
    $NNOX
    $ONMD
    Medical Electronics
    Health Care
    Biotechnology: Commercial Physical & Biological Resarch
    Medical Specialities

    Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic

    ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. USANewsGroup.com News Commentary VANCOUVER, BC, Jan. 16, 2026 /PRNewswire/ -- The medical imaging world is hitting a massive reset button as AI-driven clinical intelligence transforms how we map the human heart. With the medical image management market projected to hit $9.06 billion by 2032[1], the era of bulky, multi-million dollar hardware is giving way to agile, software-defined diagnostics. As point-of-care tools accelerate toward a $70.92 billion market[2], hospitals are trading dedicated MRI suites for bedside intelligence that delivers hospital-grade precision on a portable device. This seismic shift is placing a massive premium on the

    1/16/26 11:56:00 AM ET
    $BFLY
    $GEHC
    $HOLX
    Medical Electronics
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus

    $BFLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Phanstiel S. Louise bought $571,160 worth of shares (185,261 units at $3.08) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/17/25 4:10:13 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $64,471 worth of shares (21,370 units at $3.02) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/15/25 6:20:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $4,652,773 worth of shares (1,558,541 units at $2.99) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/5/25 5:40:49 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Butterfly Network downgraded by Oppenheimer

    Oppenheimer downgraded Butterfly Network from Outperform to Perform

    8/1/25 12:44:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Craig Hallum initiated coverage on Butterfly Network with a new price target

    Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

    7/1/25 8:24:04 AM ET
    $BFLY
    Medical Electronics
    Health Care

    William Blair initiated coverage on Butterfly Network

    William Blair initiated coverage of Butterfly Network with a rating of Outperform

    3/17/25 7:23:53 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Butterfly Network Inc.

    SCHEDULE 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    2/5/26 6:11:51 AM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 25-NSE filed by Butterfly Network Inc.

    25-NSE - Butterfly Network, Inc. (0001804176) (Subject)

    2/2/26 2:02:22 PM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form SCHEDULE 13G filed by Butterfly Network Inc.

    SCHEDULE 13G - Butterfly Network, Inc. (0001804176) (Subject)

    1/30/26 1:27:15 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO Doherty John N. sold $239,524 worth of shares (60,182 units at $3.98), decreasing direct ownership by 5% to 1,234,688 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    1/9/26 4:02:23 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Rothberg Jonathan M sold $4,695,583 worth of shares (1,140,180 units at $4.12) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    1/8/26 6:14:45 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Chief Technology Officer Ku Victor sold $137,398 worth of shares (35,968 units at $3.82), decreasing direct ownership by 4% to 811,962 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    1/7/26 4:06:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    9/3/24 7:10:06 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    8/30/24 4:05:41 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by Butterfly Network Inc.

    SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    7/8/24 4:32:42 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Leadership Updates

    Live Leadership Updates

    View All

    Butterfly Network Appoints John Doherty as Chief Financial Officer

    Seasoned finance leader brings over 25 years of leadership experience driving growth and transformation Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the appointment of John Doherty as Executive Vice President, Chief Financial Officer, effective December 8, 2025. Doherty has more than 25 years of global financial leadership experience, guiding public and private companies through major growth, transformation, and strategic transactions across the technology and telecommunications industries. Doherty joins Butterfly from Kaltura, a global leader in video SaaS solut

    10/9/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints Victor Ku as Chief Technology Officer

    Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care through portable, semiconductor-based ultrasound technology and intuitive software, today announced the appointment of Victor Ku as Senior Vice President and Chief Technology Officer (CTO). Victor will join the company in late September and will be responsible for leading Butterfly's global technology strategy, product development, and innovation roadmap. "Victor's deep expertise in semiconductor-based imaging and his proven ability to scale global product development make him a perfect fit for Butterfly's next phase of growth," said Joseph DeVivo, President and CEO of Butterfly Network. "His leadership will b

    9/9/25 8:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints Steve Cashman as Chief Business Officer

    Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company's successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman will join Butterfly's Executive Management Team, overseeing the Company's global sales, marketing, product and corporate strategy. This press release f

    9/3/24 8:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Financials

    Live finance-specific insights

    View All

    Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on February 26 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

    2/3/26 8:01:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Reports Third Quarter 2025 Financial Results

    Delivered quarterly revenue of $21.5 million in Q3, representing 5% YoY growth. Reduced quarterly cash burn to $3.9 million, a new record low for quarterly cash usage. Reaffirmed full year revenue guidance and narrowed adjusted EBITDA guidance. Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "We view this quarter as a period of foundational

    10/31/25 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will report third quarter 2025 financial results on October 31, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Megan Carlson, Interim Chief Financial Officer, will host a conference call and webcast at 8:00 am ET on October 31 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Events & Presentations. Individuals in

    10/17/25 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care